Search results
Bio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Down
Zacks via Yahoo Finance· 14 hours agoBio-Rad's (BIO) Clinical Diagnostics arm registers growth in Q1, primarily driven by an increased...
Bio-Rad Laboratories Maintains Full-Year Guide Despite Life Science Q1 Revenue Decline of 25 Percent
GenomeWeb News· 16 hours agoThis story has been updated to include additional information about Bio-Rad's Droplet Digital PCR initiatives. NEW YORK – Executives at Bio-Rad Laboratories ...
Earnings call: Bio-Rad sees decline in Q1 sales but maintains full-year outlook
Investing.com· 1 day agoIn the first quarter of 2024, Bio-Rad Laboratories, Inc. (NYSE: NYSE: BIO ) reported a decrease in...
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 18 hours agoBio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript May 7, 2024 Bio-Rad...
Annovis Bio, Inc. (NYSE:ANVS) Shares Sold by Merit Financial Group LLC
ETF DAILY NEWS· 23 hours agoMerit Financial Group LLC decreased its holdings in Annovis Bio, Inc. (NYSE:ANVS – Free Report) by 46.1% in the fourth quarter, according to its most recent filing with the ...
Analyst Report: Bio-Rad Laboratories, Inc.
Morningstar Research via Yahoo Finance· 13 hours agoBio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets ...
Xylyx Bio announces exclusive license agreement with Vanderbilt University for donor organ...
WFRV 5 Green Bay· 18 hours agoBy rehabilitating donor organs deemed unfit for transplant, the xenogeneic cross-circulation platform holds potential to eliminate transplant waitlist mortality. NEW YORK, May 8, 2024 /PRNewswire ...
Understanding the Risks of Investing in Kronos Bio Inc
Knox Daily· 6 hours agoKronos Bio Inc’s recent filing unveils that its SR VP, CORP OPERATIONS & LEGAL Frisbee Allison unloaded Company’s shares for reported $12757.0 on Feb 21 ’24. In the deal valued ...
Q1 2024 2Seventy Bio Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 hours agoParticipants Jenn Snyder; SVP, Corporate Affairs; 2Seventy Bio Inc Chip Baird; CEO; 2Seventy Bio Inc Vicki Eatwell; CFO; 2Seventy Bio ...
Bio-Rad Laboratories Inc (BIO) Q1 2024 Earnings: Mixed Results Amid Market Challenges
GuruFocus.com via Yahoo Finance· 1 day agoLife Science Segment: Experienced a significant sales decrease of 25.3% to $241.7 million,...
